GSTM1 and colorectal cancer: This underscores that GSTM1 and GSTT1 genotypes are key determinants for stratifying individuals who would derive maximum benefit from SFN-based chemoprevention for colorectal cancer, with age and smoking history providing critical contextual refinement.